B Cell–Intrinsic IDO1 Regulates Humoral Immunity to T Cell–Independent Antigens
暂无分享,去创建一个
S. Kandala | T. McGaha | Kebin Liu | M. Shimoda | K. Chaudhary | Haiyun Liu | J. Bradley | Eslam Mohamed | R. Shinde | Xia Li
[1] M. Geffard,et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.
[2] G. Prendergast,et al. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. , 2014, International immunology.
[3] D. Munn,et al. Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance , 2014, Proceedings of the National Academy of Sciences.
[4] G. Prendergast,et al. IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis , 2014, The Journal of Immunology.
[5] D. Munn,et al. GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology , 2013, Molecular and Cellular Biology.
[6] T. Manser,et al. Cutting Edge: Macrophages Are Required for Localization of Antigen-Activated B Cells to the Follicular Perimeter and the Subsequent Germinal Center Response , 2013, The Journal of Immunology.
[7] Irene Puga,et al. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes , 2013, Nature Reviews Immunology.
[8] R. Horton,et al. Visualization of splenic marginal zone B cell shuttling and follicular B cell egress , 2012, Nature.
[9] G. Prendergast,et al. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity , 2012, Immunological reviews.
[10] L. Mandik-Nayak,et al. Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice. , 2012, Arthritis and rheumatism.
[11] T. Tsubata,et al. Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells , 2012, Proceedings of the National Academy of Sciences.
[12] C. Mauri,et al. Immune regulatory function of B cells. , 2012, Annual review of immunology.
[13] Rahul Shinde,et al. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase , 2012, Proceedings of the National Academy of Sciences.
[14] S. Serrano,et al. B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2011, Nature Immunology.
[15] D. Leclerc,et al. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive. , 2011, Molecular immunology.
[16] L. Morel,et al. Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice , 2011, BMC Immunology.
[17] J. Fechner,et al. An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.
[18] M. Colonna,et al. Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response , 2010, The Journal of experimental medicine.
[19] G. Prendergast,et al. The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity1 , 2009, The Journal of Immunology.
[20] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[21] G. Prendergast,et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. , 2007, Cancer research.
[22] D. Quiceno,et al. L-arginine availability regulates T-lymphocyte cell-cycle progression. , 2007, Blood.
[23] G. Widhopf,et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.
[24] T. Espevik,et al. Toll-like receptors mediate proliferation and survival of multiple myeloma cells , 2006, Leukemia.
[25] M. Nussenzweig,et al. T-independent type II immune responses generate memory B cells , 2006, The Journal of experimental medicine.
[26] B. Baban,et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.
[27] R. Wek,et al. Phosphorylation of the α-Subunit of the Eukaryotic Initiation Factor-2 (eIF2α) Reduces Protein Synthesis and Enhances Apoptosis in Response to Proteasome Inhibition* , 2005, Journal of Biological Chemistry.
[28] K. Calame,et al. Regulation of plasma-cell development , 2005, Nature Reviews Immunology.
[29] B. Baban,et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. , 2004, The Journal of clinical investigation.
[30] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[31] C. Gélinas,et al. To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.
[32] K. Shirey,et al. Synergistic Transcriptional Activation of Indoleamine Dioxygenase by IFN-γ and Tumor Necrosis Factor-α , 2003 .
[33] K. Toellner,et al. Extrafollicular antibody responses , 2003, Immunological reviews.
[34] K. Toellner,et al. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens , 2003, European journal of immunology.
[35] B. Nardelli,et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL , 2002, Nature Immunology.
[36] J. Kearney,et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.
[37] J. Schlessinger,et al. Absence of marginal zone B cells in Pyk-2–deficient mice defines their role in the humoral response , 2000, Nature Immunology.
[38] K. Toellner,et al. T‐independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci , 1999, European journal of immunology.
[39] G. Evan,et al. Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.
[40] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[41] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.
[42] V. Braun,et al. The lipoprotein of the outer membrane of Escherichia coli: a B- lymphocyte mitogen , 1975, The Journal of experimental medicine.
[43] T. Eleftheriadis,et al. Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration , 2011, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.
[44] I. Maclennan,et al. Germinal centres in T-cell-dependent antibody responses. , 1992, Immunology today.